Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

787
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
787
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

2.7K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

1.6K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing the Uptake and Completion of the Cervical Cancer Screening Continuum: Opportunity Knocks, Including at Home.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis.

JCO oncology practice·2026
Same author

Toward equitable access to cell and gene therapies: rethinking co-payments.

The American journal of managed care·2026
Same author

Most Favored Nation Pricing and Affordability of GLP-1RAs for Obesity Treatment in Medicare.

JAMA network open·2026
Same author

Ivermectin-Benzimidazole Prescribing Following Celebrity Endorsement.

JAMA network open·2026
Same author

Telemedicine Adoption, US Ambulatory Visits, and Total Medical Spending, 2019-2023.

JAMA network open·2026
Same journal

Endovascular Therapy for Acute Ischemic Stroke: Current Evidence and Evolving Practices.

Current cardiology reports·2026
Same journal

Diagnostic Tests for Stage B Heart Failure.

Current cardiology reports·2026
Same journal

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Current cardiology reports·2026
Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026
Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026
Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K

Medication adherence and heart failure.

Eric M Riles1, Anuja V Jain, A Mark Fendrick

  • 1Cardiovascular Center, Boston Medical Center, 88 East Newton Street, Boston, MA, 02118, USA, eric.riles@bmc.org.

Current Cardiology Reports
|January 28, 2014
PubMed
Summary
This summary is machine-generated.

Improving medication adherence is key to reducing heart failure hospitalizations. Understanding patient, medical, and socioeconomic barriers helps create effective interventions for better heart failure management.

Related Experiment Videos

Last Updated: May 3, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Heart failure is a leading cause of hospitalization and high healthcare costs in the US.
  • Identifying factors influencing heart failure readmissions is crucial for resource management.
  • Medication adherence is a significant modifiable factor impacting heart failure outcomes.

Purpose of the Study:

  • To explore factors influencing hospitalization and readmission rates in heart failure patients.
  • To identify barriers to medication adherence in individuals with heart failure.
  • To inform the development of interventions aimed at improving medication adherence and patient care.

Main Methods:

  • Literature review and synthesis of identified barriers to medication adherence.
  • Analysis of factors contributing to heart failure hospitalizations and readmissions.
  • Exploration of existing and potential interventions targeting medication adherence.

Main Results:

  • Multiple barriers to medication adherence exist, categorized by patient, medical, regimen, healthcare system, and socioeconomic factors.
  • These barriers significantly impact hospitalization and readmission rates for heart failure patients.
  • Understanding these barriers is essential for designing targeted interventions.

Conclusions:

  • Addressing medication adherence barriers is vital for improving heart failure management.
  • Novel interventions are needed to enhance adherence and reduce the burden of heart failure.
  • Multifaceted approaches considering patient, systemic, and socioeconomic factors are necessary for success.